Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study
Critical Care2007Vol. 11(6), pp. R127–R127
Citations Over TimeTop 1% of 2007 papers
Catherine L. Dent, Qing Ma, Sudha Dastrala, Michael Bennett, Mark Mitsnefes, Jonathan Barasch, Prasad Devarajan
Abstract
Accurate measurements of plasma NGAL are obtained using the point-of-care Triage(R) NGAL device. Plasma NGAL is an early predictive biomarker of AKI, morbidity, and mortality after pediatric CPB.
Related Papers
- → Role of neutrophil gelatinase-associated lipocalin for early detection of acute kidney injury(2014)32 cited
- → Neutrophil gelatinase-associated lipocalin and acute kidney injury(2014)2 cited
- → Early predictive value of neutrophil gelatinase-associated lipocalin in adult ICU patients with acute kidney injury(2009)1 cited
- → Urine neutrophil gelatinase-associated lipocalin (NGAL) as an initial biomarker of acute kidney injury (AKI) in an intensive care unit (ICU) patients: a preliminary study(2019)1 cited
- The diagnostic value of N-acetyl-β-D-glocosaminidase,Kidney injury molecule and neutrophil gelatinase-associated lipocalin in patients with acute kidney injury(2013)